Effects of Gastrodia elata Bl on phencyclidine-induced schizophrenia-like psychosis in mice

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 247-250

  Shin, E J ^a   Kim, J M ^a   Nguyen, X K T ^a   Nguyen, T T L ^a   Lee, S Y ^a   Jung, J H ^a   Kim, M J ^a   Whang, W K ^b   Yamada, K ^c   Nabeshima, T ^d   Kim, H C ^a  

^a Kangwon National University   (South Korea)

^b Chung Ang University   (South Korea)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MEIJO UNIVERSITY   (Japan)

Author keywords

5 HT1A receptors; Gastrodia elata Bl; Phencyclidine; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GASTRODIA ELATA BLUME; HERBACEOUS AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GASTRODIA ELATA; IMMOBILIZATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PSYCHOSIS; RECOGNITION; SCHIZOPHRENIA; SOCIAL INTERACTION; TIME;

EID: 79953033161     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017263     Document Type: Article

References (15)

1. Andreasen, N.C.; Flaum, M.; Swayze, B.V. II; Tyrrell, G.; Arndt, S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch. Gen. Psychiatry, 1990, 47(7), 615-621.
2. Javitt, D.C.; Zukin, S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry, 1991, 148(10), 1301-1308.
3. Mouri, A.; Noda, Y.; Enomoto, T.; Nabeshima, T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem. Int., 2007, 51(2-4), 173-184.
4. Meltzer, H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 1999, 21(2 Suppl), 106S-115S.
5. Tao, Y.H. Recent progress on pharmacological effects of Gastrodia elata. Zhongguo Zhong Yao Za Zhi, 2008, 33(1), 108-110.
6. Chen, P.J.; Hsieh, C.L.; Su, K.P.; Hou, Y.C.; Chiang, H.M.; Sheen, L.Y. Rhizomes of Gastrodia elata BL possess antidepressant-like effect via monoamine modulation in subchronic animal model. Am. J. Chin. Med., 2009, 37(6), 1113-1124.
7. Krishnan, V.; Han, M.H.; Mazei-Robison, M.; Iñiguez, S.D.; Ables, J.L.; Vialou, V.; Berton, O.; Ghose, S.; Covington, H.E. III; Wiley, M.D.; Henderson, R.P.; Neve, R.L.; Eisch, A.J.; Tamminga, C.A.; Russo, S.J.; Bolanos, C.A.; Nestler, E.J. AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol. Psychiatry., 2008, 64(8), 691-700.
8. Nagai, T.; Murai, R.; Matsui, K.; Kamei, H.; Noda, Y.; Furukawa, H.; Nabeshima, T. Aripirazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology, 2009, 202(1-3), 315-328.
9. Hagiwara, H.; Fusita, Y.; Ishima, T.; Kunitachi, S.; Shirayama, Y.; Iyo, M.; Hashimoto, K. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Eur. Neuropsychopharmacol., 2008, 18(6), 448-454.
10. Ichikawa, J.; Meltzer, H.Y. Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs. Eur. Arch. Psychiatry Clin. Neurosci., 1999, 249(Suppl 4), 90-98.
11. Sumiyoshi, T; Matsui, M.; Nohara, S.; Yamashita, I.; Kurachi, M.; Sumiyoshi, C.; Jayathilake, K.; Meltzer, H.Y. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am. J. Psychiatry, 2001, 158(10), 1722-1725.
12. Blier, P.; Ward, N.M. Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry, 2003, 53(3), 193-203.
13. File, S.E.; Seth, P. A review of 25 years of the social interaction test. Eur. J. Pharmacol., 2003, 463(1-3), 35-53.
14. Rollema, H.; Lu, Y.; Schmidt, A.W.; Sprouse, J.S.; Zorn, S.H. 5-TH1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol. Psychiatry, 2000, 48(3), 229-237.
15. Green, M.F.; Kern, R.S.; Braff, D.L.; Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bull., 2000, 26(1), 119-136.